<h2>Eligibility Tool</h2>

<div class="eligibilty-wrapper">

  <div class="slider-container">
      <label>Age</label>
      <input type="range" min="1" max="5" step="1" id="styled-slider" />
      <div id="slider-value">Not selected</div>
  </div>


  <div class="custom-select no-group">
    <label data-label="anticonvulsant-therapy">Anticonvulsant Therapy</label>
    <div class="selected">
      <span class="selected-label">Choose an option</span>
      <span class="clear-selection" style="display: none;">&#10060;</span>
    </div>
    <ul class="options">
        <li data-value="1.1">
          <label>Certain anticonvulsants (Phenytoin, carbamazepine, barbiturates, primidone, topiramate, oxcarbazepine)</label>
          <span class="checkmark">&#9989;</span>
        </li>
        <li data-value="1.2">
          <label>Lamotrigine</label>
          <span class="checkmark">&#9989;</span>
        </li>
    </ul>
  </div>


  <div class="custom-select no-group">
    <label data-label="antimicrobial-therapy">Antimicrobial Therapy</label>
    <div class="selected">
      <span class="selected-label">Choose an option</span>
      <span class="clear-selection" style="display: none;">&#10060;</span>
    </div>
    <ul class="options">
        <li data-value="2.1">
          <label>Broad-spectrum antibiotics</label>
          <span class="checkmark">&#9989;</span>
        </li>
        <li data-value="2.2">
          <label>Antifungals</label>
          <span class="checkmark">&#9989;</span>
        </li>
        <li data-value="2.3">
          <label>Antiparasitics</label>
          <span class="checkmark">&#9989;</span>
        </li>
        <li data-value="2.4">
          <label>Rifampicin or rifabutin therapy</label>
          <span class="checkmark">&#9989;</span>
        </li>
    </ul>
  </div>

  
  <div class="custom-select with-group">
      <label data-label="antiretroviral-therapy">Antiretroviral Therapy</label>
      <div class="selected">
        <span class="selected-label">Choose an option</span>
        <span class="clear-selection" style="display: none;">&#10060;</span>
      </div>
      <ul class="options">
          <li class="group">Nucleoside reverse transcriptase inhibitors (NRTIs)</li>
          <ul class="group-options">
              <li data-value="1.1">
                <label>Abacavir (ABC) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Abacavir (ABC) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Tenofovir (TDF) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Tenofovir (TDF) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Zidovudine (AZT) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Zidovudine (AZT) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Lamivudine (3TC) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Lamivudine (3TC) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Didanosine (DDI) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Didanosine (DDI) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Emtricitabine (FTC) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Emtricitabine (FTC) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Stavudine (D4T) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="1.2">
                <label>Stavudine (D4T) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
          </ul>
          <li class="group">Non-nucleoside reverse transcriptase inhibitors (NNRTs)</li>
          <ul class="group-options">
              <li data-value="2.1">
                <label>Efavirenz (EFV) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.2">
                <label>Efavirenz (EFV) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Etravirine (ETR) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.2">
                <label>Etravirine (ETR) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Nevirapine (NVP) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.2">
                <label>Nevirapine (NVP) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Rilpivirine (RPV) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.2">
                <label>Rilpivirine (RPV) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
          </ul>
          <li class="group">Protease inhibitors (PIs)</li>
          <ul class="group-options">
              <li data-value="2.1">
                <label>Ritonavir-boosted atazanavir (ATV/r) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Ritonavir-boosted atazanavir (ATV/r) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Ritonavir-boosted Lopinavir (LPV/r) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.2">
                <label>Ritonavir-boosted Lopinavir (LPV/r) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Ritonavir-boosted darunavir (DVR/r) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.2">
                <label>Ritonavir-boosted darunavir (DVR/r) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Ritonavir (RTV) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.2">
                <label>Ritonavir (RTV) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
          </ul>
          <li class="group">Integrase inhibitors</li>
          <ul class="group-options">
              <li data-value="2.1">
                <label>Raltegravir (RAL) Initiation</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Raltegravir (RAL) Continuation</label>
                <span class="checkmark">&#9989;</span>
              </li>
          </ul>
      </ul>
  </div>
  

  <div class="toggle-switch-container">
    <label>Benign Ovarian Tumors (Including cysts)</label>
    <label class="switch">
        <input type="checkbox" id="toggleSwitch">
        <span class="slider-round"></span>
    </label>
  </div>


  <div class="toggle-switch-container">
    <label>Blood pressure measurement unavailable</label>
    <label class="switch">
        <input type="checkbox" id="toggleSwitch">
        <span class="slider-round"></span>
    </label>
  </div>


  <div class="custom-select with-group">
    <label data-label="antimicrobial-therapy">Antimicrobial Therapy</label>
    <div class="selected">
      <span class="selected-label">Choose an option</span>
      <span class="clear-selection" style="display: none;">&#10060;</span>
    </div>
    <ul class="options">
        <li data-value="2.1">
          <label>Undiagnosed mass</label>
          <span class="checkmark">&#9989;</span>
        </li>
        <li data-value="2.2">
          <label>Benign breast disease</label>
          <span class="checkmark">&#9989;</span>
        </li>
        <li data-value="2.3">
          <label>Family history of cancer</label>
          <span class="checkmark">&#9989;</span>
        </li>
        <li class="group">Breast cancer</li>
          <ul class="group-options">
              <li data-value="2.1">
                <label>Current</label>
                <span class="checkmark">&#9989;</span>
              </li>
              <li data-value="2.1">
                <label>Past and no evidence of current disease for 5 years</label>
                <span class="checkmark">&#9989;</span>
              </li>
          </ul>
    </ul>
  </div>





  <div class="sticky-footer">
    <div class="percentage-chart" data-value="1">
      <svg class="progress-ring" viewBox="0 0 100 100">
        <circle class="progress-ring__circle" stroke="yellow" stroke-width="8" fill="transparent" r="36" cx="50" cy="50" />
        <text class="chart-label" x="50" y="50" text-anchor="middle" dominant-baseline="middle" font-size="12" fill="#333">alp</text>
      </svg>
      <span class="chart-label">25%</span>
    </div>
    <div class="percentage-chart" data-value="2">
      <svg class="progress-ring" viewBox="0 0 100 100">
        <circle class="progress-ring__circle" stroke="orange" stroke-width="8" fill="transparent" r="36" cx="50" cy="50" />
      </svg>
      <span class="chart-label">25%</span>
    </div>
    <div class="percentage-chart" data-value="3">
      <svg class="progress-ring" viewBox="0 0 100 100">
        <circle class="progress-ring__circle" stroke="red" stroke-width="8" fill="transparent" r="36" cx="50" cy="50" />
      </svg>
      <span class="chart-label">25%</span>
    </div>
    <div class="percentage-chart" data-value="4">
      <svg class="progress-ring" viewBox="0 0 100 100">
        <circle class="progress-ring__circle" stroke="darkred" stroke-width="8" fill="transparent" r="36" cx="50" cy="50" />
      </svg>
      <span class="chart-label">25%</span>
    </div>
    <div class="percentage-chart" data-value="2">
      <svg class="progress-ring" viewBox="0 0 100 100">
        <circle class="progress-ring__circle" stroke="orange" stroke-width="8" fill="transparent" r="36" cx="50" cy="50" />
      </svg>
      <span class="chart-label">25%</span>
    </div>
    <div class="percentage-chart" data-value="3">
      <svg class="progress-ring" viewBox="0 0 100 100">
        <circle class="progress-ring__circle" stroke="red" stroke-width="8" fill="transparent" r="36" cx="50" cy="50" />
      </svg>
      <span class="chart-label">25%</span>
    </div>
  </div>
  

</div>